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Abstract 
 
Erythropoietin (EPO) is a glycoprotein hormone consists of 165 amino acids and has molecular mass of 30,400 Daltons. 
The large quantities of these hormone required to satisfy clinical demand are currently met by recombinant expression 
in mammalian cell, namely chinese hamster ovary (CHO). Pichia pastoris has become popular yeast based protein 
production systems to substitute mammalian expression systems. P. pastoris is capable to use methanol as sole carbon 
and energy source. In this study, recombinant human EPO (rhEPO) protein obtained by expressing the hEPO gene in 
methylotropic yeast P. pastoris, strain X33. The present work was carried out to study the optimal methanol 
concentration for induction and the incubation time to obtain rhEPO protein. To perform this study, the transformed P. 
pastoris was induced with various concentrations of methanol (0%, 0.5%, 1%, 2.5%, 5%, 10%, and 20%) and 
incubation times (0 hours, 24 hours, 48 hours, 72 hours, 96 hours, 120 hours, and 144 hours). The results demonstrate 
that the highest protein expression level occurred at concentration of 2.5% methanol induction, while the optimal 
incubation time was at 48 hrs.  
 
 
Abstrak 
 
Pengaruh Induksi Methanol dan Waktu Inkubasi terhadap Ekspresi Eritropoietin Manusia pada Khamir 
Metilotropik Pichia pastoris. Eritropoietin (EPO) adalah hormon glikoprotein yang terdiri dari 165 asam amino dan 
memiliki berat molekul sebesar 30.400 Daltons. Sebagian besar kebutuhan EPO didapatkan dari hasil sintesis pada sel 
mamalia Chinese hamster ovary (CHO). Pichia pastoris adalah sejenis khamir yang populer digunakan untuk 
menggantikan sistem ekspresi pada sel mamalia. P. pastoris dapat menggunakan metanol sebagai satu-satunya sumber 
energi karbon. Pada studi ini, protein rekombinan EPO (rhEPO) disintesis dengan cara mengekspresikan gen hEPO 
pada khamir metilotropik P. pastoris strain X33.  Studi ini dilakukan untuk mengetahui konsentrasi metanol dan waktu 
inkubasi yang optimal untuk mensintesis rhEPO. Pada studi ini konsentrasi metanol yang digunakan adalah 0%, 0.5%, 
1%, 2.5%, 5%, 10%, dan 20%. Sedangkan waktu inkubasi yang digunakan adalah 0 jam, 24 jam, 48 jam, 72 jam, 96 
jam, 120 jam, and 144 jam. Hasil penelitian ini menunjukkan bahwa ekspresi protein yang tertinggi terjadi pada 
konsentrasi metanol sebesar 2.5% dan waktu inkubasi selama 48 jam. 
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1. Introduction 
 
Erythropoietin (EPO), a glycoprotein hormone of 30 
Dalton produced in the adult kidney and fetal liver, 
regulates the level of erythrocytes in response to the 
level of oxygen in the blood [1]. In response to a 
decrease in tissue oxygenation, EPO synthesis increases 
in the kidney. The secreted hormone bind to specific 
receptor on the surface of red blood cell precursor in the 
bone marrow, leading to their survival, proliferation and 
differentiation, and finally increase in hematocrit [2-3]. 
It is highly effective at correcting anemia associated 
with cancer, HIV infection, myelodysplastic syndromes, 
prematurity, autologous blood donation, chronic renal 
failure, bone marrow transplantation, restoring energy 
levels and increasing patient well being and quality of 
life [4-8].  
 
The large quantities of the hormone required to satisfy 
clinical demand are currently met by recombinant 
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expression in mammalian cell, namely Chinese hamster 
ovary (CHO). However, there are significant 
disadvantages of the use of mammalian cell cultures 
with respect to efficientcy and cost [9]. Mammalian 
systems are often hampered by disadvantages such as 
long production times, low protein titers, product 
heterogeneity and viral containment issues. This can 
impose serious challenges for large scale production of 
therapeutic glycoproteins when using mammalian cell 
lines [9-11]. Consequently, there is a continual search 
for alternative expression systems with improved 
performance. 
 
Besides mammalian, another expression system 
frequently used is a prokaryotic system using bacteria. 
Some therapeutic proteins can be expressed in 
prokaryotic cells, like insulin in Escherichia coli. 
However, the majority of therapeutic proteins require 
additional post-translational modifications, like N-
glycosylation which prokaryotic cells can not provide 
[12-14]. N-glycosylation ensures proper protein 
structure, function and subsequent stability in human 
serum. Thus, the use of bacterial system for production 
of EPO protein is not suitable. This makes alternative 
system beyond mammalian and bacterial systems is 
needed.  
 
Pichia pastoris has become popular yeast based protein 
production systems to substitute mammalian and 
bacterial expression systems. Yeasts grow rapidly and 
produce proteins using a eukaryotic protein-synthesis 
pathway, and the costs of the media, equipment and 
infrastructure to culture yeast are lower than that of 
mammalian cells. Yeast can carry out glycosylation of 
the amide nitrogen of asparagine residues in a protein 
when found in the consensus sequence Asn-Xaa- 
Thr/Ser, providing N-linked glycosylation. Also, 
glycosylation of hydroxy groups of threonine and/or 
serine residues in proteins occurs in yeast cells, yielding 
O-linked type of glycosylation [15]. Practically, the 
advantages of this particular expression system can be 
attributed to several factors, most importantly: a) the 
simplicity of techniques, b) the ability of P. pastoris to 
produce foreign proteins at high levels, c) the capability 
of performing many eukaryotic post-translational 
modifications, and d) the ability of the cells to grow at 
very high density [16].  
 
P. pastoris is capable to use methanol as sole carbon 
and energy source. The methanol is oxidized by the 
alcohol oxidases of this yeast. The alcohol oxidases are 
produced by the two AOX genes of Pichia: AOX1 and 
AOX2 [4]. Where as the protein coding regions of the 
functional genes and the protein products are 92% and 
97% homologous, respectively, the promoter regions are 
distinct: AOX1 produces approximately 90% of the 
alcohol oxidase in the methanol induced state of the 
cells. The strong AOX1 promoter is used for 
constructions of recombinant protein expressing 
cassettes which are integrated into the genome of the 
yeast, resulting strains in which the recombinant protein 
production is under the control of methanol 
concentration in the media [17-18]. Thus, methanol 
serves as the inducer of product formation as well as 
energy and carbon source. 
 
Methanol induction and incubation time are both critical 
parameters for acquiring optimal results of protein 
expression in P. pastoris expression system. Therefore, 
here we used these two parameters, to know the effect 
of various methanol concentrations and duration of 
incubation times on the expression of hEPO gene in 
methylotrophic yeast P. pastoris. 
 
2. Methods 
 
Strain. The E. coli DH5alpha strain (Invitrogen, San 
Diego, USA) was used as a host for DNA manipulation 
and cultured in low-salt LB medium (1% tryptone, 0.5% 
NaCl and 0.5% yeast extract, plus 2% agar in plates). 
For screening purposes, ampicillin was added at 
standard concentrations for screening the bacteria and 
Zeocin for the selection of yeast transformant. P. 
pastoris strain X33 mut+ (wild-type) from Invitrogen Co. 
(USA) was used. It was maintained on YPD agar plate  
(1% bacto yeast extract, 2% peptone, 2% dextrose 
(glucose), and 1,7% bacto agar). 
 
Construction of the plasmid. hEPO clone (a kind gift 
of Dr. Emmanuel Payen, Laboratoire de Therapie 
Genique Hematopoietique, Paris, France) was 
subcloned into the Xho I and Xba I sites of yeast 
pPICZαB (Invitrogen, Carlsbad, CA, USA). This vector 
allows the gene of interest to be cloned into the the 
alcohol oxygenase locus of the methanotropic yeast P. 
pastoris which are integrated into the genome of the 
yeast, resulting strains in which the recombinant protein 
production is under the control of the methanol 
concentration in the media. Thus, methanol serves as the 
inducer of product formation as well as energy and 
carbon source. The resulting construct Epo/pPICZαB, 
was verified by DNA sequencing. To simplify expression 
analysis and purification, the expressed rhEPO protein 
includes C-terminal polyhistidine tag and Myc-epitope. 
The inclusion of this sequence led to increase in 
expressed protein size to become approximately 37 kDa. 
Positives clones were screened in Zeocin as described 
by manufacturer. Several clones were screened for level 
of expression of Epo protein by Western blot using 
polyclonal anti-EPO antibodies. The highest expressing 
clone was selected for subsequent study.  
 
Transformation of Pichia pastoris. Purified 
pPICZalphaB/hEPO recombinant plasmid was digested 
with BstX I (Roche), and after verifying complete 
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digestion by agarose gel electrophoresis, the plasmid 
was used for transfection of P. pastoris wild-type host 
strain X-33 using electroporator. Transformation was 
performed using electroporator Biorad Gene pulser 
XCell (Biorad). 
 
Selection of the potential rhEPO-producing strain. 
Selection of cell producing strain was performed based 
on expression level. Several clones were screened for 
level of expression of Epo protein by Western blot using 
polyclonal anti-EPO antibodies. The highest expressing 
clone was selected for subsequent study. 
 
Recombinant protein production. P. pastoris 
transformant containing recombinant human EPO 
(rhEPO) was maintained in YPD medium (1% yeast 
extract, 2% peptone and 2% dextrose, plus 2% agar in 
plates). A single colony was inoculated into 2 mL in 
buffered complex glycerol medium (BMGY) containing 
1% yeast extract, 2% peptone, 100mM Potasium 
phosphate pH 6.0, 1.34% yeast nitrogen base, 0.00001% 
biotin and 1% glycerol. Growth was allowed until OD600 
2-6 (approximately 16-18 hours). The cells harvested by 
centrifugation at 1500-3000 x g for 5 min at room 
temperature. The pellet was then resuspended in: 1) 
BMMY production medium containing 0%, 0.5%, 1%, 
2.5%, 5%, 10% and 20% of methanol and 2) BMMY 
production medium containing 2.5% methanol was 
added to the culture after 24h, 48h, 72h, 96h, 120h and 
144h incubation. After incubation times reached the 
completion, the supernatant was harvested by 
centrifugation at 3000 x g for 5 min. 
 
Measurement of cell concentrations. Cell 
concentrations were measured using a UV-Vis 
Spectrophotometer (Beckman DU 65D) at λ600nm. For 
cell counting, we refers to the Instruction Manual 
(Invitrogen) where at OD one at 600 nm = ~5 x 107 
cells/mL.  
 
SDS-PAGE and Western Blotting. SDS-
polyacrylamide gel electrophoresis (PAGE) [19] was 
performed in a 12% separating gel with a 5% stacking 
gel using the Mini-PROTEAN-3 apparatus (BioRad, 
Hercules, CA, USA). Protein was transferred from the 
gel to Hybond-ECL Nitrocellulose membrane 
(Amersham Biosciences, Germany) by electroblotting. 
Immunodetection was achieved by using anti hEPO 
antibody (Sigma, USA) as primary antibody and anti-
rabbit IgG (isolated from Goat) peroxidase conjugate 
(Promega, USA) as secondary antibody. The band was 
visualized by NBT-BCIP staining kit (Promega, USA).  
 
3. Results and Discussion 
 
The effect of methanol induction and incubation 
time on the number of P. pastoris cells. As previously 
mentioned, the overall goal of this research is to study 
the optimal methanol concentration for induction and 
the incubation time to obtain maximum amount of 
rhEPO protein production. As seen below (Table 1), 
induction of P. pastoris culture by various methanol 
concentrations strongly influences cell numbers. 
Overall, increasing methanol concentrations decreased 
the cell numbers. Meanwhile, study on incubation time 
(Table 2) showed that the longer incubation the higher 
the cell numbers and, finally, it peaked at 96 hours. The 
peak was followed by decrease in cell numbers at 120 
and 144 hour incubation times.  
 
The effect of methanol induction and incubation 
time on rhEPO expression as analyzed by Western 
blot. Western blot using antibody specific for rhEPO 
was used for analyzing the rhEPO expression levels in 
response to methanol induction and time of incubation. 
This analysis showed that the highest rhEPO expression 
level occurred at 2.5% methanol induction (Figure 1). 
The effect of methanol induction at 10 and 20% was the 
same as that of 0% methanol which gave no results in 
protein expression. Study of the effect of time 
incubation on protein expression (Figure 2) showed that, 
from 24 to 144 hours, the transformed P. pastoris 
showed positive results in Western blot analysis. 
However, the highest expression occurred at 48 hours of 
incubation time. 
 
Table 1.  The Effect of Methanol Concentration on the 
Number of P. pastoris cell. Absorbance was 
Measured at λ600nm. OD One at 600 nm = ~5 x 107 
Cells/mL 
 
Methanol conc. 
(%) Absorbance Number of cells 
0 2.95 14.75 x 107 
   0.5 2.99 14.95 x 107 
1 2.77 13.85 x 107 
   2.5 2.57 12.85 x 107 
5 2.38 11.90 x 107 
  10 2.27 11.35 x 107 
  20 2.15 10.75 x 107 
 
Table 2.  The Effect of Incubation Time on the Number of 
P. pastoris cell. Absorbance was Measured at 
λ600nm. OD One at 600 nm = ~5 x 107 Cells/mL 
 
Incubation time 
(hours) Absorbance Number of cells 
    0 2.48 12.40 x 107 
  24 2.55 12.75 x 107 
  48 2.59 12.95 x 107 
  72 2.68 13.40 x 107 
  96 2.81 14.05 x 107 
120 2.59 12.95 x 107 
144 2.55 12.75 x 107 
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Figure 1. Western Blot Analysis of Methanol Induction Effect on rhEPO Expression in P. pastoris Expression System.  
Polyclonal Antibody Specific for hEPO was used as the Primary Antibody. Inside the White Dotted Box is the 
Band that Represents the rhEPO Protein with the Size Approximately 37 kDa. Lane 1: 0% Methanol, Lane 2: 
0.5% Methanol, Lane 3: 1% Methanol, Lane 4: 2.5% Methanol, Lane 5: 5% Methanol, Lane 6: 10% Methanol, 
and Lane 7: 20% Methanol 
 
 
 
 
 
Figure 2.  Western Blot Analysis of Incubation Time Effect on rhEPO Expression in P. pastoris Expression System. 
Polyclonal Antibody Specific for hEPO was Used as the Primary Antibody. Inside the White Dotted Box is the 
Band Represents the rhEPO Protein with the Size Approximately 37 kDa. Lane 1: 144 hrs Incubation Time, Lane 
2: 120 hrs, Lane 3: 96 hrs, Lane 4: 72 hrs, Lane 5: 48, Lane 6: 24hrs, and Lane  7: 0% hrs 
 
P. pastoris is a methylotropic yeast, capable of meta-
bolizing methanol as its sole carbon source. The first 
step in the metabolism of methanol is the oxidation of 
methanol to formaldehyde using molecular oxygen by the 
enzyme alcohol oxydase. In addition to 
formaldehyde, this reaction generates hydrogen 
peroxide. To avoid the toxic effect of hydrogen 
peroxide, this metabolism occurs at a specialized cell 
organelle, called peroxisome. In this organelle, the toxic 
by-products sequestered away from the cell [17,20]. 
In this expression system, the hEPO gene was cloned 
under the control of alcohol oxidase 1 (AOX 1) 
promoter. This promoter is tightly regulated and 
induced by methanol which also serves as carbon source 
during induction. Thus, the expression level of the 
protein can be regulated simply by adjusting the amount 
of methanol concentration used in the media. 
Theoretically, higher methanol concentration led 
to higher expression level. While, low levels of 
methanol may not be enough to initiate transcription. 
   1             2               3            4              5           6             7 
rhEPO protein 
   1             2           3            4             5             6             7 
rhEPO protein 
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However, optimal concentration of methanol was 
necessary to have the balance between slightest toxic 
effect and highest protein expression [17,20-23]. 
 
To study the effect of methanol induction on the 
expression of hEPO protein, the hEPO gene was cloned 
under the control of the P. pastoris AOXI promoter. 
The construct was used to transform P. pastoris strain 
X-33. After induction, the use of S. cerevisiae alpha-
factor prepro-leader sequence will target the protein to 
the secretory pathway and finally secreted into the 
medium for simple analysis [24-25]. In this study, 
information on optimal concentration of methanol 
induction as well as variation incubation times is 
presented. Western blot analysis was used to detect the 
presence of rhEPO expression using antibody specific 
for hEPO that raised in CHO cells.  
 
Incubated under various concentration of methanol 
(Table 1), it was shown that the highest growth of P. 
pastoris cells expressing hEPO was at 0.5% of methanol 
concentration. The higher the methanol concentration 
applied to the culture, the slower the growth of the cells. 
We predicted that the slower growth of the cells was 
caused by the toxic effect of the methanol. This can be 
seen from the fact that without the addition of methanol 
(0% methanol induction), the cell growth was higher 
than that of 0.5%. Previous studies have reported that 
methanol induction above 0.5% of media can be toxic to 
the cells [26-28]. Interestingly, the highest growth of the 
cell (at 0.5% of methanol concentration) was not 
followed by the highest protein expression level (Figure 
1). In this study, the highest protein expression level 
occurred at concentration of 2.5% methanol.  
 
Although, the number of the cells at 2.5% methanol 
induction was lower than that of 0.5%, the protein 
expression level at 2.5% methanol induction was still 
higher. While the number of cells was decreasing 
because of the toxic effect, yet the induction process 
was still increasing until it peaked at 2.5% of methanol. 
Interesting to note that this result contradicts the 
previous studies where above 0.5% of methanol 
induction can be toxic to the cells [27-28] and others). 
This study proved that methanol induction in P. pastoris 
can be higher than 0.5%. In rather similar study, 
expression of SAG2 (the major surface antigens of the 
intracelluler protozoan parasite Toxoplasma gondii) in 
P. pastoris, [29] reported that 0.5–1% of methanol 
induction gave optimal expression result, while below 
0.5% or above 2% of methanol induction slightly 
reduced the expression.  
 
To further study the rhEPO expression study in P. 
pastoris, we were attempted to find the optimal 
incubation time for getting the highest protein 
expression level. Incubated under various incubation 
times (Table 2), it was shown that the highest growth of 
P. pastoris cells expressing hEPO was at 96 hrs 
incubation time. The longer the incubation time the 
higher the number of the cells until it peaked at 96 hrs 
incubation time. Interestingly, the highest number of the 
cell at 96 hrs was not followed by the highest protein 
expression level. The highest protein expression 
occurred at 48 hrs (Figure 2). This result is in line with 
several previous studies that said that 48 hrs incubation 
time is the optimal time for incubation [30-32]. Thus, 
the number of cells is not correlated with the level of 
protein expression. To make sure that the cells have 
enough methanol, during incubation time, fresh methanol 
was added everyday to induce protein expression.  
 
The fact that the number of cells that peaked at 96 hrs 
incubation time was not followed by the higher level of 
protein expression suggests that protein degradation 
may play role in this process. It is very possible that the 
longer the incubation time, the more proteolytic 
digestion occur. Theoretically, long incubation time will 
eventually result in complete degradation of the protein. 
However, in this study, Western blot analysis was still 
able to detect the presence of rhEPO protein even at 
incubation time of 144 hrs, suggesting that in our 
condition the proteolytic degradation was rather low. 
Previous studies had found that Recombinant proteins 
secreted by P. pastoris are often subjected to proteolytic 
degradation in the high cell density environment of 
bioreactor cultivation [26-28]. Intracellular vacuolar 
proteases from dead lysed cells are believed to be the 
major source of proteolytic activity in the culture 
medium because P. pastoris secretes small amounts of 
endogenous proteins. Hence controlling cell viability is 
important for controlling proteolytic degradation, most 
likely by increasing viability of cells and reducing 
activity of the proteases [27-28]. 
 
4. Conclusion 
 
P. pastoris has many advantages of higher eukaryotic 
expression system. Since the gene of interest is cloned 
under the promoter regulating the production of alcohol 
oxidase, the level of the expressed protein can be 
manipulated by the induction on methanol. By 
combining the incubation time and the optimal 
concentration of methanol, we can obtain the balance 
between slightest toxic effect and highest protein 
expression.  In the expression study of hEPO protein 
that was cloned in P. pastoris strain X33, we find that 
the highest protein expression level occurred at 
concentration of 2.5% methanol induction, while the 
optimal incubation time was at 48 hrs.  
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